A total of 13 adult patients with advanced GPC3-positive HCC received CAR T-GPC3 therapy following lymphodepletion.84 Eight out of the 13 patients experienced reversible CRS (grade 1/2), and 1 patient experienced severe CRS (grade 5). This evidence concerns the gene GPC3 and hepatocellular carcinoma.